Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04651023
Other study ID # ShanghaiMHST
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2009
Est. completion date June 20, 2009

Study information

Verified date November 2020
Source Shanghai Meiji Health Science and Technology Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23<BMI<30 kg/m2) were randomly allocated to three groups: a control group, a 1 g/day NnEx group, and a 2 g/day NnEx group. The effects of the consumption of 2 g/day or 1 g/day NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx.


Recruitment information / eligibility

Status Completed
Enrollment 95
Est. completion date June 20, 2009
Est. primary completion date May 15, 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: - Has a body mass index (BMI) of 23-30 kg/m2 - Has no history of using any antidiabetic medication - Absence of liver, kidney, or heart disease - Absence of food allergy and daily tea consumption <2 L - Meet all of the above criteria and to follow the instructions given during the study. Exclusion Criteria: - Testing delayed for >1 week without justification - Difficulty attending the hospital on the required days - Lack of data regarding the times of beverage consumption for over 5% of the study - Abnormal overeating - Test results believed to be unreliable because of the lack of provision of diet and exercise reports during the fasting period - Difficulty drawing blood - Poor confidence in the test data

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nelumbo nucifera Leaf Extract
Hot water extracted Nelumbo nucifera Leaf, mainly containing quercetin and quercetin 3-O-glucuronide.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Meiji Health Science and Technology Co., Ltd.

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in anthropometrix indices during the study weight in kilograms baseline, 6 weeks, 12 weeks
Primary Changes in anthropometrix indices during the study height in meters baseline, 6 weeks, 12 weeks
Primary Changes in anthropometrix indices during the study body fat in percentage baseline, 6 weeks, 12 weeks
Primary Changes in anthropometrix indices during the study visceral fat in percentage baseline, 6 weeks, 12 weeks
Primary Changes in anthropometrix indices during the study waist in centimeters baseline, 6 weeks, 12 weeks
Primary Changes in anthropometrix indices during the study hip in centimeters baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study glucose in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study HbA1c in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study TG in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study FFA in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study T-cho in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study HDL-cho in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study LDL-cho in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study ASP in mmol/L baseline, 6 weeks, 12 weeks
Secondary Changes in fasting biochemical indices during the study BUN in mmol/L baseline, 6 weeks, 12 weeks